Exhibit 10.1






Exhibit 10.1




SUBSCRIPTION AGREEMENT




FuelCell Energy, Inc.

3 Great Pastures Road

Danbury, CT 06813




Gentlemen:



The undersigned (the “Investor”) hereby confirms its agreement with FuelCell Energy, Inc., a
Delaware corporation (the “Company”), as follows:



1. This Subscription Agreement, including the Terms and Conditions for Purchase of Units
attached hereto as Annex I (collectively, this “Agreement”) is made as of the date set
forth below between the Company and the Investor.



2. The Company has authorized the offering, sale and issuance (the “Offering”) to certain
investors of up to an aggregate of 10,160,428 units (the “Units”), with each Unit consisting of (i)
one share (the “Share,” collectively, the “Shares”) of its common stock, par value $0.0001 per
share (the “Common Stock”), and (ii) one warrant (the “Warrant,” collectively, the “Warrants”) to
purchase 1.0 share of Common Stock (and the fractional amount being the “Warrant Ratio”), in
substantially the form attached hereto as Exhibit B, for a purchase price of $1.87 per Unit
(the “Purchase Price”). Units will not be issued or certificated. The Shares and Warrants are
immediately separable and will be issued separately. The shares of Common Stock issuable upon
exercise of the Warrants are referred to herein as the “Warrant Shares” and, together with the
Units, the Shares and the Warrants, are referred to herein as the “Securities”).



3. In addition, subject to the terms and conditions of this Agreement and the satisfaction of
the Equity Conditions (as defined in Section 3.2(c) of Annex I), at any time during the
eleven (11) Trading Days (as defined below) ending on the nine (9) month anniversary of this
Agreement (the “Additional Purchase Right Expiration Date”), or if the nine (9) month anniversary
of this agreement is not a Trading Day, then the eleven (11) Trading Days ending on the last
Trading Day prior to the nine (9) month anniversary of this agreement, (the “Additional Purchase
Right Exercise Period”), the Company will have the right and will exercise such right (the
“Additional Purchase Right”) to require the Investor to purchase up to an additional 10,000,000
shares of Common Stock (the “Additional Shares”) at a price per share equal to the Additional Share
Purchase Price (as defined below), provided, however, in no event shall the Investor be required to
purchase a number of Additional Shares with an aggregate Additional Share Purchase Price in excess
of $20,000,000. The Additional Purchase Right may only be exercised once. In the event that the
Company decides it does not wish to exercise the Additional Purchase Right, it must provide written
notice (“Cancellation Notice”) to the Investor no later than the tenth (10th) Trading
Day prior to the commencement of the Additional Purchase Right Exercise Period (such date being the
“Additional Purchase Right Cancellation Deadline”). In the event that the Company does not issue a
Cancellation Notice relating to its Additional Purchase Right, the Company will provide to the
Investor, with a copy to the Placement Agent, a schedule indicating the number of Additional
Shares and aggregate purchase price for such shares (the “Additional Shares Exercise Notice”), to
be delivered to the email address and facsimile number set forth on the Investor signature page at
any time during the Additional Purchase Right Exercise Period (but no later than the Additional
Purchase Right Expiration Date). The Additional Shares Exercise Notice shall be accompanied by the
Officers’ Certificate (as defined in Section 3.2(c), Annex I, of this Agreement). The computations
set forth in the Additional Shares Exercise Notice shall be subject to the confirmation and
agreement of the Investor.


 


 









 






	 	(a)	 	The “Additional Share Purchase Price” shall be equal to 90% of the lesser
of (1) the VWAP on the date of the Additional Shares Exercise Notice and (2) the
arithmetic average of the daily VWAPs (as defined below) for the ten (10) consecutive
Trading Days ending on the date of the Additional Shares Exercise Notice.







	 	(b)	 	“Trading Day” means any day on which the Common Stock is traded on the
NASDAQ Global Market, or, if the NASDAQ Global Market is not the principal trading
market for the Common Stock, then on the principal securities exchange or securities
market on which the Common Stock is then traded; provided that a Trading Day shall
not include any day on which the Common Stock is scheduled to trade on such
exchange or market for less than 4.5 hours or any day that the Common Stock is
suspended from trading during the final hour of trading on such exchange or market
(or if such exchange or market does not designate in advance the closing time of
trading on such exchange or market, then during the hour ending at 4:00 p.m., New
York time).







	 	(c)	 	“VWAP” means, for any date, the price determined by the first of the
following clauses that applies: (a) if the Common Stock is then listed or quoted on
the NASADQ Global Market or another Eligible Market (as defined in Section
3.2(c)), the daily volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on the NASADQ Global Market or such other
Eligible Market on which the Common Stock is then listed or quoted for trading as
reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:00 p.m. (New York City time)); (b) if the Common stock is not then listed
or quoted on the NASADQ Global Market or another Eligible Market, and if the Common
Stock is listed or quoted on the OTC Bulletin Board, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on the OTC
Bulletin Board; (c) if the Common Stock is not then listed or quoted for trading on
the OTC Bulletin Board and if prices for the Common Stock are then reported in the
“Pink Sheets” published by Pink OTC Markets, Inc. (or a similar organization or
agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported; or (d) in all other cases, the fair market
value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Investor and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.






4. The Closing of the purchase and sale of the Additional Shares shall take place in
accordance with the provisions of Section 6 and Section 3 of Annex I of this Agreement on the
Trading Day immediately following the date of the Additional Shares Exercise Notice, or in the
event no Additional Shares Exercise Notice is sent and no other notice is sent prior to the
Additional Purchase Right Cancellation Deadline, on the Additional Purchase Right Expiration Date.
The offering and sale of the Securities and Additional Shares are being made pursuant to (a) an
effective Registration Statement on Form S-3 — File No. 333-164412 (the “Registration Statement”)
filed by the Company with the Securities and Exchange Commission (the “Commission”), including the
Prospectus contained therein (the “Base Prospectus”), (b) if applicable, certain “free writing
prospectuses” (as that term is defined in Rule 405 under the Securities Act of 1933, as amended
(the “Act”)), that have been or will be filed with the Commission and delivered to the Investor on
or prior to the date hereof (the “Issuer Free Writing Prospectus”), containing pricing and related
information, (c) a Preliminary Prospectus Supplement (the “Preliminary Prospectus Supplement”)
containing certain supplemental information regarding the Securities, the terms of the Offering and
the Company and (d) a Prospectus Supplement (the “Prospectus Supplement” and, together with the
Base Prospectus, the “Prospectus”) containing certain supplemental information regarding the Shares
and Warrants included in the Units, the Additional Shares and the terms of the Offering that have
been or will be filed with the Commission and delivered to the Investor (or made available to the
Investor by the filing by the Company of an electronic version thereof with the Commission).


 


- 2 -









 





5. The Company and the Investor agree that at the Closing (as defined in Section 3.1 of Annex
I), the Investor will purchase from the Company and the Company will issue and sell to the Investor
the Units set forth below for the aggregate purchase price set forth below. The Units shall be
purchased pursuant to the Terms and Conditions for Purchase of Units attached hereto as Annex
I and incorporated herein by this reference as if fully set forth herein. The Investor
acknowledges that the Offering is not being underwritten by Lazard Capital Markets LLC (the
“Placement Agent” or “LCM”) named in the Prospectus Supplement and that there is no minimum
offering amount.



6. The manner of settlement of the Shares included in the Units and any Additional Shares
purchased by the Investor shall be as follows:




Delivery versus payment (“DVP”) through DTC (i.e., on the Closing Date and any
Additional Closing Date (each as defined in Section 3 of Annex I), the Company
shall issue Shares or Additional Shares, if any, registered in the Investor’s name and
address as set forth below and released by the Transfer Agent to the Investor through DTC
at the Closing directly to the account(s) at LCM identified by the Investor; upon receipt
of such Shares or Additional Shares, if any, LCM shall promptly electronically deliver
such shares to the Investor, and simultaneously therewith payment shall be made by LCM by
wire transfer to the Company). NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF
THIS AGREEMENT
BY THE INVESTOR AND THE COMPANY (OR ANY ADDITIONAL SHARE EXERCISE NOTICE BY THE COMPANY),
THE INVESTOR SHALL:




	 	(I)	 	NOTIFY LCM OF THE ACCOUNT OR ACCOUNTS AT LCM TO BE CREDITED WITH THE
SHARES OR ADDITIONAL SHARES, AS THE CASE MAY BE, BEING PURCHASED BY SUCH INVESTOR,
AND







	 	(II)	 	CONFIRM THAT THE ACCOUNT OR ACCOUNTS AT LCM TO BE CREDITED WITH THE
SHARES OR ADDITIONAL SHARES, IF ANY, BEING PURCHASED BY THE INVESTOR HAVE A MINIMUM
BALANCE EQUAL TO THE AGGREGATE PURCHASE PRICE FOR THE UNITS OR ADDITIONAL SHARES, AS
THE CASE MAY BE, BEING PURCHASED BY THE INVESTOR.




 


- 3 -









 










IT IS THE INVESTOR’S RESPONSIBILITY TO (A) MAKE THE NECESSARY WIRE TRANSFER OR CONFIRM THE
PROPER ACCOUNT BALANCE IN A TIMELY MANNER AND (B) ARRANGE FOR SETTLEMENT BY WAY OF DVP IN A TIMELY
MANNER. IF THE INVESTOR DOES NOT DELIVER THE AGGREGATE PURCHASE PRICE FOR THE UNITS OR
ADDITIONAL SHARES, AS THE CASE MAY BE, OR DOES NOT MAKE PROPER ARRANGEMENTS FOR SETTLEMENT IN A
TIMELY MANNER, THE SHARES AND WARRANTS OR ADDITIONAL SHARES, AS THE CASE MAY BE, MAY NOT BE
DELIVERED AT CLOSING TO THE INVESTOR OR THE INVESTOR MAY BE SUBJECT TO LIABILITY.



7. The executed Warrant included in the Units purchased by the Investor shall be delivered in
accordance with the terms thereof.



8. The Investor represents that, except as set forth below, (a) it has had no position, office
or other material relationship within the past three years with the Company or persons known to it
to be affiliates of the Company, (b) it is not a FINRA member or an Associated Person (as such term
is defined under the NASD Membership and Registration Rules Section 1011) as of the Closing, and
(c) neither the Investor nor any group of Investors (as identified in a public filing made with the
Commission) of which the Investor is a part in connection with the Offering of the Units, acquired,
or obtained the right to acquire, 20% or more of the Common Stock (or securities convertible into
or exercisable for Common Stock) or the voting power of the Company on a post-transaction basis.
Exceptions:



 




(If no exceptions, write “none.” If left blank, response will be deemed to be “none.”)




9. The Investor represents that it has received (or otherwise had made available to it by the
filing by the Company of an electronic version thereof with the Commission) the Base Prospectus
which is a part of the Company’s Registration Statement, the documents incorporated by reference
therein, any Preliminary Prospectus Supplement and any free writing prospectus (collectively, the
“Disclosure Package”), prior to or in connection with the receipt of this Agreement. The Investor
acknowledges that, prior to the delivery of this Agreement to the Company, the Investor will
receive certain additional pricing and related information regarding the Offering (the “Offering
Information”). Such information may be provided to the Investor by any means permitted under the
Act, including the Prospectus Supplement, a free writing prospectus and oral communications.



10. No offer by the Investor to buy Units will be accepted and no part of the Purchase Price
will be delivered to the Company until the Investor has received the Disclosure Package and the
Company has accepted such offer by countersigning a copy of this Agreement, and any such offer may
be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to the
Company (or LCM on behalf of the Company) sending (orally, in writing or by electronic mail) notice
of its acceptance of such offer. An indication of interest will involve no obligation or
commitment of any kind until the Investor has been delivered the Offering Information and this
Agreement is accepted and countersigned by or on behalf of the Company.



11. The Company acknowledges that the only material non-public information relating to the
Company that it has provided to the Investor in connection with the Offering prior to the date
hereof is the existence of the Offering.


 


- 4 -









 





12. For so long as any Warrants remain outstanding, the Company (including its subsidiaries)
shall not, in any manner, (a) issue or sell any rights, warrants or options to subscribe for or
purchase Common Stock, or directly or indirectly convertible into or exchangeable for Common Stock
(i) at a price which resets as a function of the market price of the Common Stock, or (ii) that has
a conversion, exercise or exchange price that is subject to being reset at some future date after
the initial issuance of such rights, warrants or options or upon the occurrence of specified or
contingent events directly or indirectly related to the business of the Company (or its
subsidiaries) or the market for the Common Stock, other than pursuant to a customary “weighted
average” anti-dilution provision, or (b) enter into any agreement (including, without limitation,
an equity line of credit or at-the-market offering) whereby the Company (or its subsidiaries) may
sell securities at a future determined price (other than standard and customary “preemptive” or
“participation” rights). The Investor shall be entitled to obtain injunctive relief against the
Company to preclude any such issuance, which remedy shall be in addition to any right to collect
damages.


 


- 5 -









 





Number of Units: 10,160,428




Purchase Price Per Unit: $1.87




Aggregate Purchase Price: $19,000,000




Additional Shares up to: 10,000,000




Please confirm that the foregoing correctly sets forth the agreement between us by signing in the
space provided below for that purpose.



	 	 	 	 	 	 	 	 
	 	 	Dated as of: January 10, 2011
	 
	 	 	 	 	 	 	 
	 	 	 	 
	 

	 	INVESTOR	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 	 	 	 	 	 
	 

	 	Print Name: 
	 	 	 	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 	 	 	 
	 	 	 	 	 	 
	 

	 	Address:	 	 	 	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	 	 	 	 






Agreed and Accepted

this 10th day of January, 2011:



FUELCELL ENERGY, INC.




	 	 	 	 	 
	By:
	 	 	 	 
	 

	 	 


	 	 
	Title:
	 	 





 


- 6 -










 





ANNEX I




TERMS AND CONDITIONS FOR PURCHASE OF UNITS AND ADDITIONAL SHARES




1. Authorization and Sale of the Units. Subject to the terms and conditions of this
Agreement, the Company has authorized the sale of the Units and the Additional Shares.




2. Agreement to Sell and Purchase the Units; Placement Agent.



2.1 At the Closing (as defined in Section 3.1), the Company will sell to the Investor,
and the Investor will purchase from the Company, upon the terms and conditions set forth herein,
the number of Units set forth on the last page of the Agreement to which these Terms and Conditions
for Purchase of Units are attached as Annex I (the “Signature Page”) for the aggregate
purchase price therefor set forth on the Signature Page. At any Additional Closing (as defined in
Section 3.1), the Company will sell to the Investor, and the Investor will purchase from
the Company, upon the terms and conditions set forth herein, the number of Additional Shares set
forth in the Additional Shares Exercise Notice for the aggregate purchase price of such shares.



2.2 Investor acknowledges that the Company has agreed to pay Lazard Capital Markets LLC (“LCM”
or the “Placement Agent”) a fee (the “Placement Fee”) in respect of the sale of Units to the
Investor, as well as upon the exercise of the Warrants and the sale of any Additional Shares.



2.3 The Company has entered into a Placement Agent Agreement, dated January 10, 2011 (the
“Placement Agreement”), with the Placement Agent that contains representations, warranties,
covenants and agreements of the Company that may be relied upon by the Investor, which shall be a
third party beneficiary thereof. The Company confirms that neither it nor any other Person acting
on its behalf has provided the Investor with any information that constitutes or could reasonably
be expected to constitute material, nonpublic information, except as will be disclosed in the
Prospectus and the Company’s Form 8-K filed with the Commission in connection with the Offering.
The Company understands and confirms that the Investor will rely on the foregoing representations
in effecting transactions in securities of the Company.




3. Closings and Delivery of the Shares, Warrants, Additional Shares and Funds.



3.1 (a) Closing. The completion of the purchase and sale of the Units (the “Closing”)
shall occur at a place and time (the “Closing Date”) to be specified by the Company and the
Placement Agent, and of which the Investors will be notified in advance by the Placement Agent, in
accordance with Rule 15c6-1 promulgated under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”). At the Closing, (i) the Company shall cause the Transfer Agent to deliver to the
Investor the number of Shares set forth on the Signature Page registered in the name of the
Investor or, if so indicated on the Investor Questionnaire attached hereto as Exhibit A, in
the name of a nominee designated by the Investor, (ii) the Company shall cause to be delivered to
the Investor a Warrant to purchase a number of whole Warrant Shares determined by multiplying the
number of Shares set forth on the signature page by the Warrant Ratio and rounding down to the
nearest whole number and (iii) the aggregate purchase price for the Units being purchased by the
Investor will be delivered by or on behalf of the Investor to the Company.


 


- 7 -









 





(b) Additional Closing. The completion of the purchase and sale of the Additional
Shares (the “Additional Closing”) shall occur on the Trading Date immediately following the date of
the Additional Shares Exercise Notice (the “Additional Closing Date”), and of which the Placement
Agent will be notified in advance by the Company, in accordance with Rule 15c6-1 promulgated under
the Exchange Act. At the Additional Closing, (a) the Company shall cause the Transfer Agent to
deliver to the Investor the number of Additional Shares set forth on the Additional Shares Exercise
Notice delivered by the Company registered in the name of the Investor or, if so indicated on the
Investor Questionnaire attached hereto as Exhibit A, in the name of a nominee designated by
the Investor and (b) 95% of the aggregate purchase price for the Additional Shares being purchased
by the Investor will be delivered by or on behalf of the Investor to the Company, and 5% of the
aggregate purchase price for the Additional Shares will be delivered to the Placement Agent for its
fee related to such Additional Shares.



3.2
Conditions to the Obligations of the Parties.





(a) Conditions to the Company’s Obligation to Sell Units. The Company’s obligation to
issue and sell the Units to the Investor shall be subject to: (i) the receipt by the Company of the
purchase price for the Units being purchased hereunder as set forth on the Signature Page and (ii)
the accuracy of the representations and warranties made by the Investor and the fulfillment of
those undertakings of the Investor to be fulfilled prior to the Closing Date.



(b) Conditions to the Investor’s Obligation to Purchase Units. The Investor’s
obligation to purchase the Units will be subject to the accuracy of the representations and
warranties made by the Company and the fulfillment of those undertakings of the Company to be
fulfilled prior to the Closing Date, including without limitation, those contained in the Placement
Agreement, and to the condition that the Placement Agent shall not have: (i) terminated the
Placement Agreement pursuant to the terms thereof or (ii) determined that the conditions to the
closing in the Placement Agreement have not been satisfied. The Investor understands and agrees
that, in the event that LCM in its reasonable discretion determines that the conditions to closing
in the Placement Agreement have not been satisfied or if the Placement Agent Agreement may be
terminated for any other reason permitted by such Agreement, then the Placement Agent may, but
shall not be obligated to, terminate such Agreement, which shall have the effect of terminating
this Subscription Agreement pursuant to Section 14 below.



 


- 8 -









 




(c) Conditions to the Investor’s Obligation to Purchase Additional Shares. The
Company’s Additional Purchase Right will be subject to the satisfaction of the following “Equity
Conditions” at the time of the Additional Share Exercise Notice and on the Additional Closing Date:
(A) the Shareholders of the Company shall have approved, and the Company shall have effected, an
amendment to its Certificate of Incorporation increasing the number of its authorized shares of
Common Stock by not less than 10,000,000 additional common shares, which amount shall be sufficient
to cover all of the Shares, Additional Shares and Warrant Shares to be issued hereunder; (B) on
each day during the period beginning thirty (30) Trading Days prior to the date of the Additional
Shares Exercise Notice and ending on and including the Additional Closing Date (the “Equity
Conditions Measuring Period”), all Additional Shares issuable hereunder and the Warrant Shares
pursuant to the Warrants shall be eligible for sale without restriction or limitation pursuant to
an effective and then usable Registration Statement or without the need for registration under any
applicable federal or state securities laws; (C) on each day during the Equity Conditions Measuring
Period, the Common Stock is designated for listing on the NASDAQ Global Market or another eligible
market (The New York Stock Exchange, Inc., The American Stock Exchange, The NASDAQ Global Select
Market or The NASDAQ Capital Market, each an “Eligible Market”) and shall not have been suspended
from trading from any applicable exchanges or markets nor shall proceedings for such delisting or
suspension from any such exchange or market have been commenced, threatened or pending either (1)
in writing by such relevant exchange and market or (2) by falling below the minimum listing
maintenance requirements of such relevant exchange and market; (D) the Company shall have delivered
Common Stock upon exercise of the Warrants to the holders on a timely basis; (E) any applicable
shares of Common Stock to be issued in connection with the event requiring determination may be
issued in full without violating the rules or regulations of the NASDAQ Global Market;
provided, however, that the foregoing shall not preclude the Company from issuing
such number of shares that does not cause any such violation; (F) during the Equity Conditions
Measuring Period, there shall not have occurred (x) a Triggering Event (as defined below) or an
event that with the passage of time or giving of notice would constitute a Triggering Event or (y)
the public announcement of a pending, proposed or intended sale or merger of the Company which has
not been abandoned, terminated or consummated; (G) the Company shall have no knowledge of any fact
that would cause any Additional Shares or Warrant Shares issuable upon exercise of the Warrants not
to be eligible for sale without restriction or limitation and without the need for registration
under any applicable federal or state securities laws; (H) the Investor shall not be in possession
of any material non-public information received from the Company or its agents or its affiliates,
(I) during the Equity Conditions Measuring Period, there shall exist no material misstatements or
omissions in the Prospectus or any reports required to be filed by the Company with the Commission
pursuant to the Exchange Act; (J) the arithmetic average of the daily VWAPs for the 25 Trading Days
during the Equity Conditions Measuring Period with the lowest daily VWAPs is not less than $1.00
(as adjusted for stock splits, stock dividends, stock combinations or other similar transactions)
and (K) the arithmetic average of the daily trading volume for the 25 Trading Days during the
Equity Conditions Measuring Period with the lowest daily trading volumes (as reported on Bloomberg)
(the “ADTV”) of the Common Stock on the NASDAQ Global Market or other Eligible Market on which the
Common Stock is listed or designated for quotation as of such date of determination is not less
than 1,000,000 shares (adjusted for any stock dividend, stock split, stock combination or other
similar transaction during such period) ); provided, however, if the ADTV during the Equity
Conditions Measuring Period (as reported on Bloomberg) of the Common Stock on the NASDAQ Global
Market or other Eligible Market on which the Common Stock is listed or designated for quotation as
of such date of determination is between 500,000 shares and 1,000,000 shares (adjusted for any
stock dividend, stock split, stock combination or other
similar transaction during such period) this Equity Condition will be deemed to be satisfied
and the number of Additional Shares will be reduced to a number determined by multiplying a)
10,000,000 by b) a fraction with a numerator equal to the ADTV and a denominator equal to
1,000,000.


 


- 9 -









 





The Company shall, concurrent with the Additional Share Exercise Notice, deliver to the
Investor a certificate of its Chief Executive Officer and its Chief Financial Officer, each in his
capacity as an officer of the Company (the “Officers’ Certificate”), certifying that (i) the Equity
Conditions are satisfied and (ii) since the date of this Agreement, the Company has timely filed
all reports required to be filed by the Company with the Commission pursuant to the Exchange Act,
and any reports required to be filed by the Company with the Commission pursuant to the Exchange
Act did not include any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading, which
untrue statements or omissions, if any, shall have been fully corrected in a subsequent report or
amendment filed by the Company at least ten (10) Trading Days prior to the Additional Closing Date.



A “Triggering Event” shall be deemed to have occurred if there shall have occurred or be
continuing any of the following events:




	 	(a)	 	while the Registration Statement is required to be maintained, the
effectiveness of the Registration Statement lapses for any reason (including,
without limitation, the issuance of a stop order) or is unavailable to the Investor
for the issuance and sale of the Additional Shares issued and issuable hereunder,
and such lapse or unavailability continues for a period of ten (10) consecutive
Trading Days;

	 
	 	(b)	 	the suspension from trading or failure of the Common Stock to be listed
on the NASDAQ Global Market or another Eligible Market for a period of ten (10)
Trading Days;

	 
	 	(c)	 	the entry by a court having jurisdiction in the premises of (i) a decree
or order for relief in respect of the Company or any subsidiary of the Company of a
voluntary case or proceeding under any applicable Federal or State bankruptcy,
insolvency, reorganization or other similar law or (ii) a decree or order adjudging
the Company or any subsidiary of the Company as bankrupt or insolvent, or approving
as properly filed a petition seeking reorganization, arrangement, adjustment or
composition of or in respect of the Company or any subsidiary of the Company under
any applicable Federal or State law or (iii) appointing a custodian, receiver,
liquidator, assignee, trustee, sequestrator or other similar official of the Company
or any subsidiary of the Company or of any substantial part of its property, or
ordering the winding up or liquidation of its affairs, and the continuance of any
such decree or order for relief or any such other decree or order unstayed and in
effect for a period of sixty (60) consecutive days; or

	 
	 	(d)	 	the commencement by the Company or any subsidiary of a voluntary case or
proceeding under any applicable Federal or State bankruptcy, insolvency,
reorganization or other similar law or of any other case or proceeding to be
adjudicated a bankrupt or insolvent, or the consent by it to the entry of a decree
or order for relief in respect of the Company or any subsidiary in an involuntary
case or proceeding under any applicable Federal or State bankruptcy, insolvency,
reorganization or other similar law or to the commencement of any bankruptcy or
insolvency case or proceeding against it, or the filing by it of a petition or
answer or consent seeking reorganization or relief under any applicable Federal or
State law, or the consent by it to the filing of such petition or to the appointment
of or taking possession by a custodian, receiver, liquidator, assignee, trustee,
sequestrator or other similar official of the Company or any subsidiary or of any
substantial part of its property, or the making by it of an assignment for the
benefit of creditors, or the admission by it in writing of its inability to pay its
debts generally as they become due, or the taking of corporate action by the Company
or any subsidiary in furtherance of any such action.




 


- 10 -









 





	 	(e)	 	the Company has breached any representation, warranty, covenant or other
term or condition of this Agreement or the Placement Agreement, except, in the case
of a breach of a covenant which is curable, only if such breach remains uncured for
a period of at least five (5) Business Days.






3.3 Delivery of Funds — Units.



Delivery Versus Payment through The Depository Trust Company. No later than one
(1) business day after the execution of this Agreement by the Investor and the Company, the
Investor shall confirm that the account or accounts at LCM to be credited with the Units being
purchased by the Investor have a minimum balance equal to the aggregate purchase price for the
Units being purchased by the Investor.




3.4 Delivery of Shares and Warrants Contained in the Units.



No later than one (1) business day after the execution of this Agreement by the Investor
and the Company, the Investor shall notify LCM of the account or accounts at LCM to be credited
with the Shares being purchased by such Investor. On the Closing Date, the Company shall deliver
the Shares to the Investor through DTC directly to the account(s) at LCM identified by Investor and
simultaneously therewith payment shall be made by LCM by wire transfer to the Company. Also on the
Closing Date, the Company will cause physical certificates of each Warrant purchased by the
Investor to be delivered by overnight courier directly to the Investor or at such other place as
the Investor may direct.




3.5 Delivery of Funds — Additional Shares.



Delivery Versus Payment through The Depository Trust Company. No later than one
(1) business day after the exercise by the Company of its Additional Purchase Right, the
Investor shall confirm that the account or accounts at LCM to be credited with the Additional
Shares being purchased by the Investor have a minimum balance equal to the aggregate purchase price
for the Additional Shares being purchased by the Investor.




3.6 Delivery of Additional Shares.



No later than one (1) business day after the exercise by the Company of its
Additional Purchase Right, the Investor shall notify LCM of the account or accounts at LCM
to be credited with the Additional Shares being purchased by such Investor. On the Additional
Closing Date, the Company shall deliver the Additional Shares to the Investor through DTC directly
to the account(s) at LCM identified by Investor and simultaneously therewith payment shall be made
by LCM by wire transfer to the Company.




 


- 11 -









 




4. Representations, Warranties and Covenants of the Investor.



The Investor acknowledges, represents and warrants to, and agrees with, the Company and the
Placement Agent that:



4.1 The Investor (a) is knowledgeable, sophisticated and experienced in making, and is
qualified to make decisions with respect to, investments in shares presenting an investment
decision like that involved in the purchase of the Units, including investments in securities
issued by the Company and investments in comparable companies, (b) has answered all questions on
the Signature Page and the Investor Questionnaire and the answers thereto are true and correct as
of the date hereof and will be true and correct as of the Closing Date and (c) in connection with
its decision to purchase the number of Units set forth on the Signature Page, has received (or had
full access to) and is relying only upon the Disclosure Package and the documents incorporated by
reference therein and the Offering Information.



4.2 (a) No action has been or will be taken in any jurisdiction outside the United States by
the Company or the Placement Agent that would permit an offering of the Units, or possession or
distribution of offering materials in connection with the issue of the Securities in any
jurisdiction outside the United States where action for that purpose is required, (b) if the
Investor is outside the United States, it will comply with all applicable laws and regulations in
each foreign jurisdiction in which it purchases, offers, sells or delivers Securities or has in its
possession or distributes any offering material, in all cases at its own expense and (c) the
Placement Agent is not authorized to make and has not made any representation, disclosure or use of
any information in connection with the issue, placement, purchase and sale of the Units, except as
set forth or incorporated by reference in the Base Prospectus or the Prospectus Supplement.



4.3 (a) The Investor has full right, power, authority and capacity to enter into this
Agreement and to consummate the transactions contemplated hereby and has taken all necessary action
to authorize the execution, delivery
and performance of this Agreement, and (b) this Agreement constitutes a valid and binding
obligation of the Investor enforceable against the Investor in accordance with its terms, except as
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting creditors’ and contracting parties’ rights generally and except as
enforceability may be subject to general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or at law) and except as to the
enforceability of any rights to indemnification or contribution that may be violative of the public
policy underlying any law, rule or regulation (including any federal or state securities law, rule
or regulation).



4.4 The Investor understands that nothing in this Agreement, the Prospectus or any other
materials presented to the Investor in connection with the purchase and sale of the Units
constitutes legal, tax or investment advice. The Investor has consulted such legal, tax and
investment advisors and made such investigation as it, in its sole discretion, has deemed necessary
or appropriate in connection with its purchase of Units. The Investor also understands that there
is no established public trading market for the Warrants being offered in the Offering, and that
the Company does not expect such a market to develop. In addition, the Company does not intend to
apply for listing the Warrants on any securities exchange. Without an active market, the liquidity
of the Warrants will be limited.


 


- 12 -









 





4.5 Since the date on which the Placement Agent first contacted the Investor about the
Offering, the Investor has not disclosed any information regarding the Offering to any third
parties (other than its legal, accounting and other advisors) and has not engaged in any purchase
or sales involving the securities of the Company (including, without limitation, any Short Sales
involving the Company’s securities). The Investor covenants that it will not engage in any
purchases or sales in the securities of the Company (including Short Sales) prior to the time that
the transactions contemplated by this Agreement with respect to the sale of the Units are publicly
disclosed. The Investor agrees that it will not use any of the Units acquired pursuant to this
Agreement to cover any short position in the Common Stock if doing so would be in violation of
applicable securities laws. For purposes hereof, “Short Sales” include, without limitation, all
“short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act,
whether or not against the box, and all types of direct and indirect stock pledges, forward sales
contracts, options, puts, calls, short sales, swaps, “put equivalent positions” (as defined in Rule
16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and
sales and other transactions through non-US broker dealers or foreign regulated brokers.



4.6 During the period beginning on the Additional Purchase Right Cancellation Deadline and
ending on the Additional Purchase Right Expiration Date, the Investor may not sell (long or short)
on any Trading Day during such period a number of shares of Common Stock that is in excess of 7.5%
of the aggregate dollar trading volume (as reported on Bloomberg) of the Common Stock on the NASDAQ
Global Market or such other Eligible Market on such Trading Day; provided that the restriction set
forth in this Section 4.6 shall not apply from and after the date of the Additional Shares
Exercise Notice. During the sixty (60) day period ending on the date of the Additional Shares
Exercise Notice, the Company and each of the Company’s officers and directors shall not directly or
indirectly engage in any purchases of Common Stock or securities convertible into or exchangeable
or exercisable for Common Stock.



5. Survival of Representations, Warranties and Agreements; Third Party Beneficiary.
Notwithstanding any investigation made by any party to this Agreement or by the Placement Agent,
all covenants, agreements, representations and warranties made by the Company and the Investor
herein will survive the execution of this Agreement, the delivery to the Investor of the Shares,
Warrants and any Additional Shares, if any, being purchased and the payment therefor. The
Placement Agent and Lazard Fréres & Co. shall be third party beneficiaries with respect to the
representations, warranties and agreements of the Investor in Section 4 hereof.



6. Notices. All notices, requests, consents and other communications hereunder will be in
writing, will be mailed (a) if within the domestic United States by first-class registered or
certified airmail, or nationally recognized overnight express courier, postage prepaid, or by
facsimile or (b) if delivered from outside the United States, by International Federal Express or
facsimile, and (c) will be deemed given (i) if delivered by first-class registered or certified
mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized
overnight carrier, one business day after so mailed, (iii) if delivered by International Federal
Express, two business days after so mailed and (iv) if delivered by facsimile, upon electronic
confirmation of receipt and will be delivered and addressed as follows:




	 	(a)	 	if to the Company, to:

	 
	 	 	 	FuelCell Energy, Inc.

3 Great Pastures Road

Danbury, CT 06813

Attention Ross Levine, Esq., Corporate Legal

Facsimile: (203) 825-6069




 


- 13 -









 





	 	 	 	With copies to:

	 
	 	 	 	Patterson Belknap Webb & Tyler LLP

1133 Avenue of the Americas

New York, NY 10036

Attention: Peter Schaeffer, Esq.

Facsimile: (212) 336-1244

	 
	 	 	 	And to:

	 
	 	 	 	Richard A. Krantz, Esq.

Robinson & Cole LLP

1055 Washington Boulevard

Stamford, CT 06901

Facsimile: (203) 462-7599

	 
	 	(b)	 	if to the Investor, at its address on the
Signature Page hereto, or at such other address or addresses as may have
been furnished to the Company in writing.

	 
	 	(c)	 	if to the Placement Agent, to:

	 
	 	 	 	Lazard Capital Markets LLC

30 Rockefeller Plaza

New York, New York 10020

Attention: General Counsel

Facsimile: (212) 830-3615






7. Changes. This Agreement may not be modified or amended except pursuant to an instrument in
writing signed by the Company and the Investor.



8. Headings. The headings of the various sections of this Agreement have been inserted for
convenience of reference only and will not be deemed to be part of this Agreement.



9. Severability. In case any provision contained in this Agreement should be invalid, illegal
or unenforceable in any respect, the validity, legality and enforceability of the remaining
provisions contained herein will not in any way be affected or impaired thereby.



10. Governing Law. This Agreement will be governed by, and construed in accordance with, the
internal laws of the State of New York, without giving effect to the principles of conflicts of law
that would require the application of the laws of any other jurisdiction.



11. Counterparts. This Agreement may be executed in two or more counterparts, each of which
will constitute an original, but all of which, when taken together, will constitute but one
instrument, and will become effective when one or more counterparts have been signed by each party
hereto and delivered to the other parties. The Company and the Investor acknowledge and agree that
the Company shall deliver its counterpart to the Investor along with the Prospectus Supplement (or
the filing by the Company of an electronic version thereof with the Commission).


 


- 14 -









 





12. Confirmation of Sale. The Investor acknowledges and agrees that such Investor’s receipt
of the Company’s signed counterpart to this Agreement, together with the Prospectus Supplement (or
the filing by the Company of an electronic version thereof with the Commission), shall constitute
written confirmation of the Company’s sale of Units to such Investor.



13. Press Release. The Company and the Investor agree that the Company shall issue a press
release and file a Form 8-K announcing the Offering and disclosing all material terms and
conditions of the Offering prior to the opening of the financial markets in New York City on the
business day immediately after the date hereof. In addition, in the event that the Company
exercises the Additional Purchase Right, it shall issue a press release and file a Form 8-K
announcing the exercise of the Additional Purchase Right and disclosing all material terms and
conditions of the Additional Purchase Right prior to the opening of the financial markets in New
York City on the business day immediately after the date of the Additional Shares Exercise Notice.



14. Termination. In the event that the Placement Agreement is terminated by the Placement
Agent pursuant to the terms thereof, this Agreement shall terminate without any further action on
the part of the parties hereto.



 


- 15 -









 








Exhibit A




FUELCELL ENERGY, INC.




INVESTOR QUESTIONNAIRE




Pursuant to Section 3 of Annex I to the Agreement, please provide us with the
following information:



	 	 	 	 	 
	1. The exact name that your Shares, Additional Shares and Warrants are
to be registered in. You may use a nominee name if appropriate:
	 	 	                    	 
	 
	 	 	 	 
	2. The relationship between the Investor and the registered holder
listed in response to item 1 above:
	 	 	                    	 
	 
	 	 	 	 
	3. The mailing address of the registered holder listed in response to
item 1 above:
	 	 	                    	 
	 
	 	 	 	 
	4. The Social Security Number or Tax Identification Number of the
registered holder listed in the response to item 1 above:
	 	 	                    	 
	 
	 	 	 	 
	5. Name of DTC Participant (broker-dealer at which the account or
accounts to be credited with the Shares and Additional Shares are
maintained):
	 	 	                    	 
	 
	 	 	 	 
	6. DTC Participant Number:
	 	 	                    	 
	 
	 	 	 	 
	7. Name of Account at DTC Participant being credited with the Shares
and Additional Shares:
	 	 	                    	 
	 
	 	 	 	 
	8. Account Number at DTC Participant being credited with the Shares
and Additional Shares:
	 	 	                    	 





 












 





Exhibit B




Form of Warrant